SCHEMBL30124869

SCHEMBL30124869

Cn1ccn(-c2ccc(-c3cc(F)cc(-c4ccnc(-c5ccncc5)c4)c3O)cc2Cl)c1=O

nearest known ligand 0.33

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ROS1 P08922 2/20 0.33
▸ GRM1 Q13255 1/20 0.33
▸ GRM4 Q14833 1/20 0.33
▸ CAPN1 P07384 3/20 0.33
▸ GSK3B P49841 3/20 0.33
▸ RPS6KA3 P51812 2/20 0.33
▸ KDR P35968 2/20 0.33
▸ MAP4K4 O95819 2/20 0.33
▸ CDC7 O00311 1/20 0.33
▸ PLK4 O00444 1/20 0.33
▸ MAPK13 O15264 1/20 0.33
▸ DAPK3 O43293 1/20 0.33
▸ DYRK3 O43781 1/20 0.33
▸ ROCK2 O75116 1/20 0.33
▸ RPS6KA5 O75582 1/20 0.33
▸ PRKD3 O94806 1/20 0.33
▸ PRKCG P05129 1/20 0.33
▸ INSR P06213 1/20 0.33
▸ CDK1 P06493 1/20 0.33
▸ CSF1R P07333 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL24720126 1.00 ROS1 (0.33) ROS1GRM1GRM4CAPN1GSK3B
SCHEMBL24952807 0.91 ROS1 (0.33) ROS1GRM1GRM4CAPN1GSK3B
SCHEMBL30124605 0.91 ROS1 (0.44) ROS1CAPN1CSNK1DCDK9BACE1
SCHEMBL24720266 0.91 ROS1 (0.44) ROS1CAPN1CSNK1DCDK9BACE1
SCHEMBL30124212 0.88 CAPN1 (0.42) GRM1GRM4CAPN1RPS6KA3CSNK1D
SCHEMBL24719482 0.88 CAPN1 (0.42) GRM1GRM4CAPN1RPS6KA3CSNK1D
SCHEMBL30123954 0.83 CDK9 (0.38) CDK9
SCHEMBL24719843 0.83 CDK9 (0.38) CDK9
SCHEMBL24720559 0.83 KMO (0.37) GRM1GRM4
SCHEMBL24720319 0.82 NMT1 (0.39) METCSNK1DDYRK1A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-4351560-A1 ANTICANCER COMPOUNDS The Regents of the University of California (US) 2024-04-17 — — EP disclosed
CN-117794525-A Anticancer compounds 加利福尼亚大学董事会 2024-03-29 — — CN disclosed
WO-2022261204-A1 ANTICANCER COMPOUNDS THE REGENTS OF THE UNIVERSITY OF CALIFORNIA (US) 2022-12-15 — — WO disclosed
WO-2022104079-A1 PYRAZOLO[1,5-A]PYRAZINE DERIVATIVES AS BTK INHIBITORS BIOGEN MA INC. (US) 2022-05-19 — — WO disclosed
Send feedback